$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq

$icdiq Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000153702822000026 Filed on May 16, 2022

Income Statement

Concept	2022 Q1	2021 Q4	2021 Q1
Revenue	$34.99M	$28.56M	$15.54M
YoY Change	125.14%	114.44%	-59.62%
Cost Of Revenue	$27.17M	$24.05M	$14.54M
YoY Change	86.83%	94.24%	-51.9%
Gross Profit	$7.826M	$4.514M	$1.000M
YoY Change	682.6%	380.21%	-87.91%
Gross Profit Margin	22.37%	15.8%	6.43%
Selling, General & Admin	$5.228M	$3.870M	$3.686M
YoY Change	41.83%	14.5%	-1.99%
% of Gross Profit	66.8%	85.73%	368.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.751M	$9.671M	$9.990M
YoY Change	-2.39%	-8.59%	-13.28%
% of Gross Profit	124.6%	214.24%	999.0%
Operating Expenses	$5.228M	$13.69M	$3.686M
YoY Change	41.83%	-1.93%	-1.99%
Operating Profit	-$6.637M	-$9.177M	-$12.28M
YoY Change	-45.96%	-76.67%	-50.2%
Interest Expense	-$4.675M	-$3.899M	-$3.709M
YoY Change	26.04%	2.07%	3.03%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$59.52M	-$13.04M	-$15.99M
YoY Change	272.18%	-69.79%	-43.42%
Income Tax	-$720.0K	$18.45M	$34.00K
% Of Pretax Income
Net Earnings	-$58.80M	-$31.48M	-$16.03M
YoY Change	266.9%	-26.94%	-43.22%
Net Earnings / Revenue	-168.03%	-110.23%	-103.11%
Basic Earnings Per Share	-$5.20		-$2.58
Diluted Earnings Per Share	-$5.20	-$3.224M	-$2.58
COMMON SHARES
Basic Shares Outstanding	11.30M	9.563M	6.215M
Diluted Shares Outstanding	11.30M		6.215M

Balance Sheet

Concept	2022 Q1	2021 Q4	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.342M	$4.140M	$5.400M
YoY Change	73.0%	-66.34%	-44.9%
Cash & Equivalents	$9.342M	$4.140M	$5.440M
Short-Term Investments
Other Short-Term Assets	$9.000K	$9.000K	$4.400M
YoY Change	-99.8%	125.0%	-55.1%
Inventory	$1.301M	$1.171M	$1.100M
Prepaid Expenses
Receivables	$24.23M	$22.21M	$10.34M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$39.42M	$32.31M	$21.28M
YoY Change	85.28%	17.74%	-55.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$360.0M	$363.8M	$375.7M
YoY Change	-4.17%	-4.83%	-14.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.201M	$2.449M	$3.271M
YoY Change	-32.71%	-30.58%	18.77%
Total Long-Term Assets	$361.0M	$364.8M	$377.0M
YoY Change	-4.26%	-5.44%	-14.36%
TOTAL ASSETS
Total Short-Term Assets	$39.42M	$32.31M	$21.28M
Total Long-Term Assets	$361.0M	$364.8M	$377.0M
Total Assets	$400.4M	$397.1M	$398.3M
YoY Change	0.52%	-3.9%	-18.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.83M	$15.30M	$4.837M
YoY Change	289.27%	275.83%	-67.71%
Accrued Expenses	$10.55M	$11.25M	$9.472M
YoY Change	11.33%	4.87%	-26.9%
Deferred Revenue	$1.701M	$542.0K	$208.0K
YoY Change	717.79%	355.46%	-58.81%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.902M	$0.00	$12.10M
YoY Change	-67.75%	-100.0%	266.67%
Total Short-Term Liabilities	$33.28M	$38.29M	$26.40M
YoY Change	26.04%	70.68%	-28.55%
LONG-TERM LIABILITIES
Long-Term Debt	$120.1M	$141.7M	$133.0M
YoY Change	-9.7%	3.01%	-8.47%
Other Long-Term Liabilities	$1.894M	$2.811M	$2.655M
YoY Change	-28.66%	3.96%	121.62%
Total Long-Term Liabilities	$1.894M	$2.811M	$2.655M
YoY Change	-28.66%	3.96%	121.62%
TOTAL LIABILITIES
Total Short-Term Liabilities	$33.28M	$38.29M	$26.40M
Total Long-Term Liabilities	$1.894M	$2.811M	$2.655M
Total Liabilities	$251.2M	$201.9M	$165.5M
YoY Change	51.81%	21.48%	-10.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$392.6M	-$333.8M	-$283.1M
YoY Change	38.67%	24.98%	42.51%
Common Stock	$545.7M	$532.9M	$519.8M
YoY Change	4.98%	2.88%	2.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.923M	$3.923M	$3.913M
YoY Change	0.26%	0.26%	0.0%
Treasury Stock Shares	$81.85K	$81.85K	78.58K shares
Shareholders Equity	$149.2M	$195.2M	$232.8M
YoY Change
Total Liabilities & Shareholders Equity	$400.4M	$397.1M	$398.3M
YoY Change	0.52%	-3.9%	-18.37%

Cashflow Statement

Concept	2022 Q1	2021 Q4	2021 Q1
OPERATING ACTIVITIES
Net Income	-$58.80M	-$31.48M	-$16.03M
YoY Change	266.9%	-26.94%	-43.22%
Depreciation, Depletion And Amortization	$9.751M	$9.671M	$9.990M
YoY Change	-2.39%	-8.59%	-13.28%
Cash From Operating Activities	-$1.661M	-$1.876M	-$6.290M
YoY Change	-73.59%	-72.41%	-303.49%
INVESTING ACTIVITIES
Capital Expenditures	$6.279M	-$6.723M	$1.742M
YoY Change	260.45%	336.56%	-80.94%
Acquisitions
YoY Change
Other Investing Activities	$589.0K	$188.0K	$650.0K
YoY Change	-9.38%	-92.93%	-15.58%
Cash From Investing Activities	-$5.690M	-$6.535M	-$1.088M
YoY Change	422.98%	-683.48%	-86.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.55M	8.249M	539.0K
YoY Change	2228.94%	-1070.47%	-94.51%
NET CHANGE
Cash From Operating Activities	-1.661M	-1.876M	-6.290M
Cash From Investing Activities	-5.690M	-6.535M	-1.088M
Cash From Financing Activities	12.55M	8.249M	539.0K
Net Change In Cash	5.202M	-162.0K	-6.839M
YoY Change	-176.06%	-97.52%	-250.41%
FREE CASH FLOW
Cash From Operating Activities	-$1.661M	-$1.876M	-$6.290M
Capital Expenditures	$6.279M	-$6.723M	$1.742M
Free Cash Flow	-$7.940M	$4.847M	-$8.032M
YoY Change	-1.15%	-192.15%	32.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11303000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6215000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.20
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.58
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001537028
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	2079000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9342000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4140000
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1171000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4549000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4787000
CY2022Q1	us-gaap	Assets Current AssetsCurrent	39423000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	32309000
CY2022Q1	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	358760000
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	362346000
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2201000
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24231000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22211000
CY2022Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1301000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2449000
CY2022Q1	us-gaap	Assets Assets	400384000
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.20
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.58
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2022Q1	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	0
CY2022Q3	icd	Debt Conversion Threshold Period Following Written Notice After Which Election Becomes Effective DebtConversionThresholdPeriodFollowingWrittenNoticeAfterWhichElectionBecomesEffective	P61D
CY2020Q2	icd	Debt Instrument Accrued And Unpaid Interest Only Payment Period DebtInstrumentAccruedAndUnpaidInterestOnlyPaymentPeriod	P3M
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-36590
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	Independence Contract Drilling, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1653648
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	20475 State Highway 249
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77070
CY2022Q1	dei	City Area Code CityAreaCode	281
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	598-1230
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
CY2022Q1	dei	Trading Symbol TradingSymbol	ICD
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13617005
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10545000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15617000
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2902000
CY2021Q4	us-gaap	Assets Assets	397104000
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	3902000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	4464000
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	18829000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15304000
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	33276000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38287000
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	120099000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	141740000
CY2022Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	77589000
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	18310000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	19037000
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1894000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2811000
CY2022Q1	us-gaap	Liabilities Liabilities	251168000
CY2021Q4	us-gaap	Liabilities Liabilities	201875000
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13698851
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10287931
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13617005
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10206085
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	136000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	102000
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	545575000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	532826000
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-392572000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-333776000
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	81846
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	81846
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	3923000
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3923000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	149216000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	195229000
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	400384000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	397104000
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34991000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15542000
CY2022Q1	us-gaap	Direct Operating Costs DirectOperatingCosts	27165000
CY2021Q1	us-gaap	Direct Operating Costs DirectOperatingCosts	14541000
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5228000
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3686000
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9751000
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9989000
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	43000
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	516000
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	435000
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	41628000
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	27824000
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6637000
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12282000
CY2022Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-4675000
CY2021Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3709000
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46347000
CY2022Q1	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	1857000
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-59516000
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15991000
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-720000
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58796000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-16025000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.20
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.58
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11303000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6215000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	195229000
CY2022Q1	icd	Stock Issued During Period Value Restricted Stock Units Vested Net Of Shares Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockUnitsVestedNetOfSharesWithheldForTaxes	32000
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3360000
CY2022Q1	icd	Stock Issued During Period Value Restructuring StockIssuedDuringPeriodValueRestructuring	9163000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	292000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58796000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	149216000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	247033000
CY2021Q1	icd	Stock Issued During Period Value Restricted Stock Units Vested Net Of Shares Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockUnitsVestedNetOfSharesWithheldForTaxes	11000
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	521000
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	874000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	454000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-16025000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	232846000
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-58796000
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-16025000
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	9751000
CY2021Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	9989000
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	43000
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	731000
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	537000
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	516000
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	435000
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	3193000
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46347000
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	250000
CY2021Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	279000
CY2022Q1	icd	Amortization Of Convertible Notes Issuance Costs And Debt Discount AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount	370000
CY2022Q1	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	1857000
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-727000
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	34000
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	60000
CY2021Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	317000
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	130000
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33000
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-386000
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-323000
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2358000
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-685000
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1661000
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6290000
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6279000
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1742000
CY2022Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	589000
CY2021Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	654000
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5690000
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1088000
CY2022Q1	icd	Payments Of Merger Consideration PaymentsOfMergerConsideration	2902000
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	32000
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6601000
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1194000
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	837000
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12553000
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	539000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5202000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6839000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4140000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12279000
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9342000
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5440000
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	4262000
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	3171000
CY2022Q1	icd	Purchases Of Property Plant And Equipment In Accounts Payable PurchasesOfPropertyPlantAndEquipmentInAccountsPayable	-701000
CY2021Q1	icd	Purchases Of Property Plant And Equipment In Accounts Payable PurchasesOfPropertyPlantAndEquipmentInAccountsPayable	70000
CY2022Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	604000
CY2021Q1	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	376000
CY2022Q1	icd	Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets	7000
CY2021Q1	us-gaap	Transfer Of Portfolio Loans And Leases To Held For Sale1 TransferOfPortfolioLoansAndLeasesToHeldForSale1	550000
CY2022Q1	icd	Non Cash Or Part Non Cash Expenses Restructuring Fees NonCashOrPartNonCashExpensesRestructuringFees	9163000
CY2022Q1	icd	Market Price Of Oil MarketPriceOfOil	123.64
CY2022Q2	icd	Natural Gas Price NaturalGasPrice	7.48
CY2022Q1	icd	Number Of Rigs Operating And Under Construction NumberOfRigsOperatingAndUnderConstruction	17
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1036000
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	34991000
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15542000
CY2022Q1	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	24254000
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	604000
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	376000
CY2021Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	22167000
CY2022Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1701000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	542000
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	505000
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	119000
CY2022Q1	icd	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	1664000
CY2021Q1	icd	Contract With Customer Liability Increase From Cash Receipts ContractWithCustomerLiabilityIncreaseFromCashReceipts	208000
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1701000
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2022Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	1400000
CY2021Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	600000
CY2022Q1	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	2000000.0
CY2022Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1200000
CY2021Q1	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	500000
CY2021Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	400000
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	194000
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	235000
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1397000
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	550000
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	123000
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	97000
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	315000
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	259000
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	114000
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	166000
CY2022Q1	icd	Finance Lease Cost FinanceLeaseCost	429000
CY2021Q1	icd	Finance Lease Cost FinanceLeaseCost	425000
CY2022Q1	us-gaap	Lease Cost LeaseCost	2143000
CY2021Q1	us-gaap	Lease Cost LeaseCost	1307000
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	186000
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	241000
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	113000
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	164000
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1194000
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	837000
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	873000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	671000
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1288000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1437000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	693000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1729000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1544000
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	15551000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	14989000
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	2268000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	1989000
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	13283000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	13000000
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3902000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4464000
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1270000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1305000
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	5172000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	5769000
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M18D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1093
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1084
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0846
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0864
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	613000
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	3864000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	760000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1282000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	372000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	282000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	41000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0
CY2022Q1	icd	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	0
CY2022Q1	icd	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	297000
CY2022Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	1368000
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	618000
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	647000
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	575000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1745000
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	5469000
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	201000
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1544000
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	5172000
CY2022Q1	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-1900000
CY2022Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	77600000
CY2022Q1	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2022Q1	us-gaap	Debt Instrument Term DebtInstrumentTerm	P4Y
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	2403000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3463000
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	671000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	693000
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1116000
CY2022Q1	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	122000
CY2021Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	122000
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	9000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9000
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4549000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4787000
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2706000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4154000
CY2022Q1	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	1659000
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	2523000
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1701000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	542000
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1731000
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2594000
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	961000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4372000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	739000
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10545000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	15617000
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	5172000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	5769000
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	170470000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	147952000
CY2022Q1	icd	Convertible Notes Issuance Costs And Debt Discount ConvertibleNotesIssuanceCostsAndDebtDiscount	46469000
CY2021Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	1748000
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3902000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4464000
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	120099000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	141740000
CY2022Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	77600000
CY2020Q2	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0075
CY2020Q2	icd	Debt Instrument Direct Reduction From Face Amount DebtInstrumentDirectReductionFromFaceAmount	1000000.0
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	731000
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	537000
CY2021Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27867
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	254.80
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	27867
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	254.80
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	5.73
CY2022Q1	us-gaap	Shares Outstanding SharesOutstanding	13617005
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	81846
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58796000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-16025000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.20
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.58
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11303000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6215000
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11303000
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6215000
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5432373
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.012
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2022Q1	us-gaap	Purchase Obligation PurchaseObligation	1800000
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	78900000
CY2022Q1	icd	Investor S Rights Agreement Number Of Directors Who Can Be Nominated InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated	1
CY2022Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	25000000.0
CY2022Q1	icd	Investor S Rights Agreement Number Of Directors Who Can Be Nominated InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated	1
CY2022Q1	icd	Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector	2
CY2022Q1	icd	Number Of Additional Representative To Be Appointed As Individual Director NumberOfAdditionalRepresentativeToBeAppointedAsIndividualDirector	1

Files In Submission

Name	View Source	Status
0001537028-22-000026-index-headers.html	Edgar Link	pending
0001537028-22-000026-index.html	Edgar Link	pending
0001537028-22-000026.txt	Edgar Link	pending
0001537028-22-000026-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icd-20220331.xsd	Edgar Link	pending
icd-20220331ex31111acda.htm	Edgar Link	pending
icd-20220331ex312f535c6.htm	Edgar Link	pending
icd-20220331ex3214c9e2b.htm	Edgar Link	pending
icd-20220331ex32206c58c.htm	Edgar Link	pending
icd-20220331x10q.htm	Edgar Link	pending
icd-20220331x10q_htm.xml	Edgar Link	completed
icd-20220331_cal.xml	Edgar Link	unprocessable
icd-20220331_def.xml	Edgar Link	unprocessable
icd-20220331_lab.xml	Edgar Link	unprocessable
icd-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq

2022 Q1 Form 10-Q Financial Statement

#000153702822000026 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICDIQ Independence Contract Drilling, Inc. Stock $icdiq

2022 Q1 Form 10-Q Financial Statement

#000153702822000026 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq